Company Overview of Revivicor, Inc.
Revivicor, Inc. is a regenerative medicine company that focuses on applying animal biotechnology platforms to provide a human-compatible alternative tissue source for the treatment of human degenerative disease. It focuses on developing and producing genetically engineered pigs to provide human compatible cells for the treatment of diabetes, and organs and tissues for use in transplant surgery. The company was founded in 2003 and is based in Blacksburg, Virginia. As of July 11, 2011, Revivicor, Inc. operates as a subsidiary of United Therapeutics Corporation.
1700 Kraft Drive
Blacksburg, VA 24060
Founded in 2003
Key Executives for Revivicor, Inc.
Revivicor, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Revivicor, Inc., please visit www.revivicor.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.